4155 — OK Biotech Co Cashflow Statement
0.000.00%
Last trade - 00:00- TWD2.61bn
- TWD3.11bn
- TWD1.67bn
- 44
- 34
- 39
- 31
Annual cashflow statement for OK Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 152 | 46.1 | 176 | 8.03 | 127 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -27.4 | -11.3 | 44.8 | 8.5 | 2.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -26.7 | -68.9 | -47.8 | -89.1 | -136 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 148 | 21.9 | 241 | 2.93 | 65.9 |
| Capital Expenditures | -79.8 | -86.5 | -294 | -437 | -377 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -47.2 | -88 | 0.011 | 78.7 | -67.8 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -127 | -174 | -294 | -358 | -445 |
| Financing Cash Flow Items | 5.29 | 0 | — | — | 6.15 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 216 | 186 | 50.3 | 82.1 | 338 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 234 | 33.1 | -3.44 | -273 | -45.6 |